News Listing

CMS has posted 2024 MIPS measure specifications for Part B Claims and CQMs.

CMS has released guidelines on Payment of Codes for Chemotherapy Administration and Nonchemotherapy Injections and Infusions

AstraZeneca will host a one-hour webinar designed for Office Managers that will review Health Disparities in Systemic Lupus Erythematosus (SLE).

Help commercial patients start SAPHNELO today at no cost*...

*For eligible commercially insured patients only. Subject to applicable insurance plan’s eligibility rules and requirements; restrictions may apply.

The weeks from October to January make up some of the happiest times of the year, but they can also be some of the most challenging for medical professionals. If you are facing holiday overload, follow these few steps to help you achieve work/life balance and a little peace this season.

Learn more about the AstraZeneca Access 360™ program and access the HCP Access & Reimbursement Guide for SAPHNELO...

On November 2, 2023 the Centers for Medicare and Medicaid Services (CMS) released the Calendar Year (CY) 2024 Medicare Physician Fee Schedule (PFS) final rule, updating payment rates for PFS services, the Quality Payment Program (QPP), and other key policies impacting providers paid under the PFS. The finalized policies are effective beginning January 1, 2024...

Per the CMS press release: Overall, the finalized CY 2024 PFS conversion factor is $32.74, a decrease of $.1.15, or 3.4%, from CY 2023.  However, we note that the preamble of the rule has the following language...

Important: Orencia IV Reverification Update
This year BMS will require an account tax ID to process benefit reverifications. The tax ID number will enable On Call to complete more patient benefit reverifications electronically.

Effective October 16th, 2023, GSK’s Benlysta Copay program is changing. Healthcare providers and patients have been informed of the change through multiple rounds of communication.